跳至主要内容
临床试验/JPRN-jRCTs041230110
JPRN-jRCTs041230110招募中1 期

Phase I Trial on the safety of Olprinone for Low Central Venous Pressure Management Aimed at Hemorrhage Control During Laparoscopic Hepatectomy

Sugiura Teiichi0 个研究点目标入组 30 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 75age old(—)
性别
All

入选标准

  • (1) A laparoscopic hepatectomy is scheduled.
  • (2) The registered age is between 18 and 75 years old.
  • (3) Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is 0 or 1.
  • (4) There's no obstructive ventilatory impairment (Forced Expiratory Volume in 1 second (FEV1.0%) is >= 70%).
  • (5) There's no history of angina or myocardial infarction.
  • (6) No moderate to severe valvular disease (based on the findings from a transthoracic echocardiogram).
  • (7) All the following conditions are met:
  • White blood cell count: between 2,500/mm3 and 10,000/mm3
  • Platelet count >=100,000/mm3
  • AST <=100IU/L
  • ALT <=100IU/L
  • Total bilirubin <=2.0 mg/dL (<=4.0mg/dL in cases with jaundice)
  • Serum creatinine <=1.0mg/dL
  • (8) Written consent for trial participation has been obtained from the patient.

排除标准

  • (1) Cases with a history of arrhythmia. (Premature ventricular contractions are not included.)
  • (2) Cases where surgery is conducted without discontinuing antiplatelet drugs.
  • (3) Cases with a history of hypersensitivity to PDEIII inhibitors.
  • (4) Cases deemed unsuitable for this trial by the attending physician.

研究者

发起方
Sugiura Teiichi

相似试验